Mechanism of HBD-3 deficiency in atopic dermatitis

Clinical Immunology

Volumn 121, Issue 3, 2006, Pages 332-338

  Howell, Michael D ^a,b   Boguniewicz, Mark ^a,b   Pastore, Saveria ^c   Novak, Natalija ^e   Bieber, Thomas ^e   Girolomoni, Giampiero ^d   Leung, Donald Y M ^a,b  

^a NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

^d UNIVERSITY OF VERONA   (Italy)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

Antimicrobial peptides; Cytokines; Extrinsic atopic dermatitis; Intrinsic atopic dermatitis

Indexed keywords

BETA DEFENSIN 3; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4;

ADULT; ARTICLE; ATOPIC DERMATITIS; BETA DEFENSIN 3 DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EXTRINSIC ATOPIC DERMATITIS; FEMALE; HUMAN; IMMUNE RESPONSE; INTRINSIC ATOPIC DERMATITIS; KERATINOCYTE; MALE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION;

ADULT; BETA-DEFENSINS; CELLS, CULTURED; CYTOKINES; DERMATITIS, ATOPIC; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION MEDIATORS; KERATINOCYTES; MIDDLE AGED; PSORIASIS; TH2 CELLS;

EID: 33751116548     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.08.008     Document Type: Article

References (38)

1. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
2. Boguniewicz M., and Leung D.Y.M. 10. Atopic dermatitis. J. Allergy Clin. Immunol. 117 (2006) S475-S480
3. Leung D.Y.M., Boguniewicz M., Howell M.D., Nomura I., and Hamid Q.A. New insights into atopic dermatitis. J. Clin. Invest. 113 (2004) 651-657
4. Novak N., and Bieber T. Allergic and nonallergic forms of atopic diseases. J. Allergy Clin. Immunol. 112 (2003) 252-262
5. Akdis C.A., Akdis M., Simon D., Dibbert B., Weber M., Gratzl S., Kreyden O., Disch R., Wuthrich B., Blaser K., and Simon H. T cells and T cell-derived cytokines as pathogenic factors in the nonallergic form of atopic dermatitis. J. Invest. Dermatol. 113 (1999) 628-634
6. Jeong C.W., Ahn K.S., Rho N.K., Park Y.D., Lee D.Y., Lee J.H., Lee E.S., and Yang J.M. Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin. Exp. Allergy 33 (2003) 1717-1724
7. Kagi M.K., Wuthrich B., Montano E., Barandun J., Blaser K., and Walker C. Differential cytokine profiles in peripheral blood lymphocyte supernatant and skin biopsies from patients with different forms of atopic dermatitis, psoriasis, and normal individuals. Int. Arch. Allergy Immunol. 103 (1994) 332-340
8. Asadullah K., Sterry W., Stephanek K., Jasulaitis D., Leupold M., Audring H., Volk H.-D., and Docke W.-D. IL-10 is a key cytokine in psoriasis. J. Clin. Invest. 101 (1998) 783-794
9. Howell M.D., Novak N., Bieber T., Pastore S., Girolomoni G., Boguniewicz M., Streib J.E., Wong C., Gallo R.L., and Leung D.Y.M. IL-10 down-regulates anti-microbial peptide expression in atopic dermatitis. J. Invest. Dermatol. 125 (2005) 738-745
10. Laouini D., Alenius H., Bryce P., Oettgen H., Tsitsikov E., and Geha R.S. IL-10 is critical for Th2 responses in a murine model of allergic dermatitis. J. Clin. Invest. 112 (2003) 1058-1066
11. Ohmen J.D., Hanifin J.M., Nickoloff B.J., Rea T.H., Wyzykowski R., Kim J., Jullien D., McHugh T., Nassif A.S., Chan S.C., and Modlin R.L. Overexpression of IL-10 in atopic dermatitis. contrasting cytokine patterns with delayed-type hypersensitivity reactions. J. Immunol. 154 (1995) 1956-1963
12. Lester M.R., Hofer M.F., Gately M., Trumble A., and Leung D.Y.M. Down-regulating effects of IL-4 and IL-10 on the IFN-γ response in atopic dermatitis. J. Immunol. 154 (1995) 6174-6181
13. Harder J., Bartels J., Christophers E., and Schroder J.M. Isolation and characterization of human β-defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276 (2001) 5707-5713
14. Midorikawa K., Ouhara K., Komatsuzawa H., Kawai T., Yamada S., Fujiwara T., Yamazaki K., Sayama K., Taubman M.A., Kurihara H., Hashimoto K., and Sugai M. Staphylococcus aureus susceptibility to innate antimicrobial peptides, B-defensins and CAP18, expressed by human keratinocytes. Infect. Immun. 71 (2003) 3730-3739
15. Maisetta G., Batoni G., Esin S., Raco G., Bottai D., Favilli F., Florio W., and Campa M. Susceptibility of Streptococcus mutans and Actinobacillus actinomycetemcomitans to bactericidal activity of human beta-defensin 3 in biological fluids. Antimicrob. Agents Chemother. 49 (2005) 1245-1248
16. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., Darst M.A., Gao B., Boguniewicz M., Travers J.B., and Leung D.Y.M. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J. Immunol. 171 (2003) 3262-3269
17. Hauk P.J., Hamid Q.A., Chrousos G.P., and Leung D.Y.M. Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. J. Allergy Clin. Immunol. 105 (2000) 782-787
18. Pastore S., Fanales-Belasio E., Albanesi C., Chinni L.M., Giannetti A., and Girolomoni G. Granulocyte macrophage colony-stimulating factor is overproduced by keratinocytes in atopic dermatitis. implications for sustained dendritic cell activation in the skin. J. Clin. Invest. 99 (1997) 3009-3017
19. Erdag G., and Morgan J.R. Interleukin-1a and interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann. Surg. 235 (2002) 113-124
20. Liu A.Y., Destoumieux D., Wong A.V., Park C.H., Valore E.V., Liu L., and Ganz T. Human β-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J. Invest. Dermatol. 118 (2002) 275-281
21. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., and Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N. Engl. J. Med. 347 (2002) 1151-1160
22. Hamid Q.A., Boguniewicz M., and Leung D.Y.M. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J. Clin. Invest. 94 (1994) 870-876
23. Seifert M., Gruenberg B.H., Sabat R., Donner P., Gruetz G., Volk H.-D., Wolk K., and Asadullah K. Keratinocyte unresponsiveness towards interleukin-10: lack of specific binding due to deficient IL-10 receptor 1 expression. Exp. Dermatol. 12 (2003) 137-144
24. Harder J., Bartels J., Christophers E., and Schroder J.M. A peptide antibiotic from human skin. Nature 387 (1997) 861
25. Gallo R.L., Murakami M., Ohtake T., and Zaiou M. Biology and clinical relevance of naturally occurring antimicrobial peptides. J. Allergy Clin. Immunol. 110 (2002) 823-831
26. Howell M.D., Gallo R.L., Boguniewicz M., Jones J.F., Wong C., Streib J.E., and Leung D.Y.M. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006) 341-348
27. Howell M.D., Wollenberg A., Gallo R.L., Flaig M., Streib J.E., Wong C., Pavicic T., Boguniewicz M., and Leung D.Y.M. Cathelicidin deficiency predisposes to eczema herpeticum. J. Allergy Clin. Immunol. 117 (2006) 836-841
28. Nizet V., Ohtake T., Lauth X., Trowbridge J., Rudisill J., Dorschner R.A., Pestonjamasp V., Piraino J., Huttner K.M., and Gallo R.L. Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature 414 (2001) 454-457
29. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., Nakanishi K., Yoshida N., Kishimoto T., and Akira S. Essential role of STAT6 in IL-4 signalling. Nature 380 (1996) 627-630
30. Takeda K., Kamanaka M., Tanaka T., Kishimoto T., and Akira S. Impaired IL-13 mediated functions of macrophages in STAT6-deficient mice. J. Immunol. 157 (1996) 3220-3222
31. Ohmori Y., and Hamilton T.A. Interleukin-4/STAT6 represses STAT1 and NF-kB-dependent transcription through distinct mechanisms. J. Biol. Chem. 275 (2000) 38095-38103
32. Chernoff A.E., Granowitz E.V., Shapiro L., Vannier E., Lonnemann G., Angel J.B., Kennedy J.S., Rabson A.R., Wolff S.M., and Dinarello C.A. A randomized, controlled trial of IL-10 in humans: inhibition of inflammatory cytokine production and immune responses. J. Immunol. 154 (1995) 5492-5499
33. D'Andrea A., Aste-Amezaga M., Valiante N.M., Ma X., Kubin M., and Trinchieri G. Interleukin 10 (IL-10) inhibits human lymphocyte interferon g-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells. J. Exp. Med. 178 (1993) 1041-1048
34. de Waal Malefyt R., Abrams J.S., Zurawski S.M., Lecron J.C., Mohan-Peterson S., Sanjanwala B., Bennett B., Silver J., de Vries J.E., and Yssel H. Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ Th0, Th1 and Th2 T cell clones and EBV-transformed B cells. Int. Immunol. 7 (1995) 1405-1416
35. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., and O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J. Immunol. 147 (1991) 3815-3822
36. Ito S., Ansari P., Sakatusume M., Deickensheets H., Vazquez N., Donnelly R.P., Larner A.C., and Finbloom D.S. Interleukin-10 inhibits expression of both interferon a- and interferon g-induced genes by suppressing tyrosine phosphorylation. Blood 93 (1999) 1456-1463
37. Song M.M., and Shuai K. The Suppressor of Cytokine Signaling (SOCS) 1 and SOCS3 but Not SOCS2 proteins inhibit interferon-mediated antiviral and antiproliferative activities. J. Biol. Chem. 273 (1998) 35056-35062
38. Grossman R.M., Krueger J., Yourish D., Granelli-Piperno A., Murphy D.P., May L.T., Kupper T.S., Sehgal P.B., and Gottlieb A.B. Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured keratinocytes. Proc. Natl. Acad. Sci. 86 (1989) 6367-6371